180 Day Money Back Guarantee
400,000 happy customers
Sons Minoxidil Spray
From £16.50/ month
Sons’ Minoxidil hair loss spray reactivates and revitalises shrunken hair follicles by increasing blood and oxygen flow to the scalp.
Easy application nozzle
Results in 6-12 months
Free aftercare support
Money back guarantee
Get Started
Is this plan right for me?
Minoxidil topical spray is the most-used medication for men experiencing mild hair loss, with early signs of a receding hairline or thinning crown.
This plan is suitable for men aged 18-65 years.
Usage
The recommended dose is to spray 1ml/10 pumps twice-a-day – ideally in the morning and evening. Your hair and scalp must be dry when applying the spray. Spread the solution across the treatment area using your fingertips, then wash your hands.
As with all treatment, please read the product information leaflet that is included with your products.
Consistency is key. Keep up your routine to see the best results.
How does minoxidil work?
In simple terms, Minoxidil increases blood flow to the scalp, providing hair follicles with vital nutrients and oxygen. This nourishment gives damaged follicles the opportunity to recover from the damage caused by male pattern hair loss.
If successful, consistent Minoxidil consumption could deliver results in between 6-12 months.
"Hair loss isn't just about your hair. It's about how you show up in the world. Getting your confidence back means reclaiming parts of your life you didn't even realize you'd lost." — Dr Adrian Gilbane, Co-Founder & PhD Scientist
Over 400,000 men
Proven results
Real results from real customers
"I have been using the Sons products for quite a few months now and 100% can see a massive difference in the thickness of my hair."
James
"I'm a long term customer, good product, good customer service. Price is reasonable, no need to look elsewhere."
Adam
"Amazing products, done my hair so good with my receding hairline, delivery was on time and fast, customer service was great."
Lewis
"Great results. Helpful staff that go above and beyond. Overall excellent company to deal with."
Dena
Get Started
Capsules vs Spray
Choose what works for your lifestyle
Capsules
One pill daily
Discreet and portable
Easy to travel with
Spray
Spray twice a day
Topical treatment
Targeted application
Real results take consistency
Month 0-3: Reset phase
Some shedding is normal as weak hairs make way for stronger ones.
Month 3-6: Stabilisation
Stabilisation. Hair loss slows significantly and existing hair becomes stronger.
Month 6-12: Regrowth
New hair starts filling in thinning areas with improved density.
Get Started
Money back guarantee
Our clinically-backed treatments have been proven to halt hair loss for 94% of men. And if you're one of the small few who don't respond after 180 days, you can claim your money back.
Answer some questions about your hair health and your medical history
Our medical team recommend the best plan for you
Your products are delivered quickly and discreetly to your door
Get Started
Not all hair loss treatments are created equal. Here's what sets Sons apart from other brands.
UK License Holder
B Corp Certified
180 Day Money Back Guarantee
Discreetly Delivered
Affordable Pricing
£0.45/ day
Other Brands
£0.75/ day
Stop Waiting. Start Now. Get Your Confidence Back.
94% effectiveness rate
400,000+ men treated
Only UK license holder for both proven treatments
180-day money-back guarantee
Free delivery
Cancel anytime, no commitment
Get Started
Get Started
References
* American Hair Loss Association (n.d.) Men’s Hair Loss. Available at: https://www.americanhairloss.org/mens-hair-loss/
**Pierard-Franchimont, C., et al. (2005) ‘Randomized, double-blind, placebo-controlled study of ketoconazole shampoo versus tar shampoo in the treatment of dandruff,’ Dermatology, 211(3), pp. 233–237. Available at: https://pubmed.ncbi.nlm.nih.gov/16307704/
***Sons (n.d.) Study & Evidence Overview. Available at: https://sons.co.uk/pages/study
**** Hu, R. (2015) ‘Combined treatment with oral finasteride and topical minoxidil in male androgenetic alopecia: a randomized and comparative study’, Dermatologic Therapy, 28(5), pp. 303–308.